Video game tech could make oral cancer surgery more precise
NCT ID NCT07466810
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a mixed reality system, similar to video game technology, can help surgeons remove oral cancer and rebuild the area more accurately. Thirty people with oral cancer will be split into three groups: one using mixed reality, one using a virtual surgical guide, and one having standard surgery. The goal is to see if the mixed reality approach leads to a better match between the rebuilt tissue and the original defect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mixed reality technology (Unreal Engine 5-based)
- What this could lead to
- If successful, this could make oral cancer surgery more accurate, improving how well rebuilt tissue matches the original shape and reducing complications.
- What could go wrong
- This is a small, early exploratory trial with only 30 people, so results may not apply to everyone. The technology is new and may not work better than current methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FREE FLAP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a glowing drug light up head and neck tumors?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- New tracheostomy tube holder aims to cut infections and boost comfort
- HIV and cancer: study seeks to uncover hidden risk factors
- New drug combo targets HPV-Driven cancers in phase II trial
- New surgical flap aims to restore swallowing and speech in obese tongue cancer patients